Erythropoietin prevents motor neuron apoptosis and neurologic disability in experimental spinal cord ischemic injury - Wikidata - wikimedia - TriplyDB

Erythropoietin prevents motor neuron apoptosis and neurologic disability in experimental spinal cord ischemic injury

Erythropoietin prevents motor neuron apoptosis and neurologic disability in experimental spinal cord ischemic injury

http://www.wikidata.org/entity/Q24530090

about

Recent trends in erythropoietin-mediated neuroprotection Asialoerythropoietin is not effective in the R6/2 line of Huntington's disease mice Unexpected benefits of intermittent hypoxia: enhanced respiratory and nonrespiratory motor function Erythropoietin protects cardiomyocytes from cell death during hypoxia/reperfusion injury through activation of survival signaling pathways Tumor necrosis factor α primes cerebral endothelial cells for erythropoietin-induced angiogenesis Erythropoietin reduces myocardial infarction and left ventricular functional decline after coronary artery ligation in rats.Post-ischemic continuous infusion of erythropoeitin enhances recovery of lost memory function after global cerebral ischemia in the rat.Protective effect of erythropoietin on renal injury induced in rats by four weeks of exhaustive exercise.Effects of tacrolimus and erythropoietin in experimental spinal cord lesion in rats: functional and histological evaluation.Rehabilitation Treatment and Progress of Traumatic Brain Injury Dysfunction EPO receptor gain-of-function causes hereditary polycythemia, alters CD34 cell differentiation and increases circulating endothelial precursors.Serum erythropoietin levels in patients with central serous chorioretinopathy.Erythropoietin facilitates the recruitment of bone marrow mesenchymal stem cells to sites of spinal cord injury.Improved cerebrovascular function and reduced histological damage with darbepoietin alfa administration after cortical impact injury in rats Erythropoietin improves neurobehavior by reducing dopaminergic neuron loss in a 6‑hydroxydopamine‑induced rat model Recombinant human erythropoietin counteracts secondary injury and markedly enhances neurological recovery from experimental spinal cord trauma.Erythropoietin administration protects retinal neurons from acute ischemia-reperfusion injury.Methylprednisolone neutralizes the beneficial effects of erythropoietin in experimental spinal cord injury.Exogenous erythropoietin protects against dorsal root ganglion apoptosis and pain following peripheral nerve injury.Endothelial nitric oxide synthase mediates the cerebrovascular effects of erythropoietin in traumatic brain injury Effects of intraosseous erythropoietin during hemorrhagic shock in swine.Promises and pitfalls in erythopoietin-mediated tissue protection: are nonerythropoietic derivatives a way forward?Clinical and experimental advances in regeneration of spinal cord injury.Erythropoietin promotes survival of primary human endothelial cells through PI3K-dependent, NF-kappaB-independent upregulation of Bcl-xL.Recombinant human erythropoietin protects the myocardium from ischemia-reperfusion injury and promotes beneficial remodeling.Asialoerythropoietin is a nonerythropoietic cytokine with broad neuroprotective activity in vivo.Dose-dependent neurorestorative effects of delayed treatment of traumatic brain injury with recombinant human erythropoietin in rats Nanomedicine for treating spinal cord injury.Pharmacological treatment of delayed cerebral ischemia and vasospasm in subarachnoid hemorrhage.Erythropoietin mediated bone formation is regulated by mTOR signaling.A re-assessment of erythropoietin as a neuroprotective agent following rat spinal cord compression or contusion injury.Human dental pulp-derived stem cells promote locomotor recovery after complete transection of the rat spinal cord by multiple neuro-regenerative mechanisms Erythropoietin accelerates functional recovery after peripheral nerve injury.Use of exogenous erythropoietin in critically ill patients.Does erythropoietin protect the preterm brain?Protecting mitochondrial bioenergetic function during resuscitation from cardiac arrest.Attenuation of inflammation and apoptosis by pre- and posttreatment of darbepoetin-alpha in acute liver failure of mice The neuroprotective effect of treatment with curcumin in acute spinal cord injury: laboratory investigation.A novel protective effect of erythropoietin in the infarcted heart Exercise preconditioning improves traumatic brain injury outcomes.

P2860

Q24649547-8C3DD7C1-982A-4185-936B-867A7D283FD4 Q24795623-C48F652B-E2E6-4C58-9A9A-F2AC2E7C4F96 Q27000674-A7575237-8432-43D9-8BC7-AA1015CBCFC4 Q27347504-D25951B9-B048-4847-BA83-2D765D560BAB Q28572003-EB6D6B7E-EDB8-47B8-A1F6-F25D61A55E00 Q30480727-3E552F94-24A2-4983-ABD6-462874A74953 Q31112997-649B4862-9DC7-46F4-B2EF-E6DEBC76F93B Q31121975-1E51F884-99D9-4FC7-8507-93DE3D3EA23B Q33586620-8B2945DF-9719-4CDA-8777-A2012A564D81 Q33604756-7A17D1DA-8D6C-4BED-855E-7D0788288A56 Q33654147-5CF9D8B5-0BF6-4C03-AE2E-D8A885C9B01B Q33702107-2FDDCD0C-446F-4B22-975F-AE5785CC34A1 Q33723789-8B114A83-EBAC-4FEC-9623-54FC1B514B80 Q33804787-FBEFB524-D879-4322-BE8C-CE4172B29B6F Q33890267-61BF8D47-4D3F-4B9F-B44B-C10931A4826A Q34035654-17F0578C-FA65-4098-8EDC-7B1489C82241 Q34075461-0B1E54BB-8133-4B87-A852-21ACB0B0A09F Q34132516-37689296-1E87-491A-8415-8370EED506D6 Q34265287-43FCE7EB-205F-4CE1-8251-0FB2D0F28214 Q34312731-959FA2DE-DC56-45A9-8061-6E6CAEB57A21 Q34445203-1B53F044-761D-4C10-BAB9-F7B3EE3628B5 Q34504572-335D8C8F-FD0C-41F6-A102-7EA42ECF496D Q34591366-E2A4F4E3-9E70-44B5-A9C7-3C13CFB1A493 Q34604185-30FF1354-C01B-4660-A7D3-9A5246015525 Q34960679-76D4B721-B23D-44EA-BF83-514EBE466346 Q35144156-4485A0E1-6CD2-42AF-BDDE-487899559571 Q35194540-129639A8-8F24-4FC3-819D-47CCF1460D8C Q35216746-CF992EE0-2E58-4681-9C04-0623D0D9B234 Q35574105-262AE277-BC29-4BDF-8E6A-A7C460D645EC Q35613027-11DD3102-3AC1-4DA5-B16D-DBAFBA43CF6A Q35634959-DED95B0C-C653-4365-944D-7773D8E47341 Q35640614-4D49736F-6250-4E43-B395-494C363123ED Q35750138-B95FD5C2-D2DD-40F1-8435-52071008843E Q35778123-251638B8-0005-4449-ABDB-B839432ECBC2 Q35813472-9E94772E-6054-4D88-AADC-D583CD784ED1 Q35846720-86126A22-0EAE-439D-8BA6-43BB4538588C Q35855561-62AA43DA-C9CA-4EF5-9134-392057096C0C Q35943787-17062412-70F3-4610-AF97-12AC5C5D9551 Q36001255-8D1C7850-723B-4D1F-8F7E-11C276512F20 Q36037599-228C91AC-EB31-4FC2-BB5E-31B229FDBD8C

P2860

Erythropoietin prevents motor neuron apoptosis and neurologic disability in experimental spinal cord ischemic injury

http://www.wikidata.org/entity/Q24530090

description

2002 nî lūn-bûn

@nan

2002 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

name

Erythropoietin prevents motor ...... al spinal cord ischemic injury

@ast

Erythropoietin prevents motor ...... al spinal cord ischemic injury

@en

Erythropoietin prevents motor ...... al spinal cord ischemic injury

@en-gb

Erythropoietin prevents motor ...... al spinal cord ischemic injury

@nl

type

label

Erythropoietin prevents motor ...... al spinal cord ischemic injury

@ast

Erythropoietin prevents motor ...... al spinal cord ischemic injury

@en

Erythropoietin prevents motor ...... al spinal cord ischemic injury

@en-gb

Erythropoietin prevents motor ...... al spinal cord ischemic injury

@nl

prefLabel

Erythropoietin prevents motor ...... al spinal cord ischemic injury

@ast

Erythropoietin prevents motor ...... al spinal cord ischemic injury

@en

Erythropoietin prevents motor ...... al spinal cord ischemic injury

@en-gb

Erythropoietin prevents motor ...... al spinal cord ischemic injury

@nl

P1433

Q24530090-2635E3A0-7C02-4133-BE73-FCFEAFBF401D

P1476

Q24530090-60BEEB2B-0F6D-4B0B-A711-6A11A85F7C8A

P2093

Q24530090-0D493074-A80D-43DC-9EA9-40A211FE34BA

Q24530090-65482767-D143-4AA2-A4B7-BEA1D4974036

Q24530090-6DAD7161-493C-4878-B682-04541FDBCD8C

Q24530090-6E58CEBD-6C06-4CD2-B74E-D36109A60DF3

Q24530090-7778C40D-0445-4C35-98A3-6518519EEC91

Q24530090-8357E183-CD36-4C0B-A64E-0F99B521D8C4

Q24530090-8B4A3818-E0CA-4640-B562-65FA7770FE52

Q24530090-9D81427C-B13C-4512-99F0-22E4E390C7DC

Q24530090-D66E5F7B-F615-4D13-A07E-6BD750F2EEF1

P2860

Q24530090-02597DDD-9883-4FD9-A957-01E6BDADE3E2

Q24530090-0661A169-56EF-4161-9355-38E7CF93883D

Q24530090-0D59D29A-60AE-460B-8F25-0EA4EBB1CD39

Q24530090-10F097BD-9E1E-47A8-97DD-0DBB93755FE2

Q24530090-1DD10404-3C37-49BC-B889-A0158925D1E7

Q24530090-5F638868-BBBE-4CB3-9914-5BE6035C29E8

Q24530090-5F772935-C689-40B6-8F6E-FEBA66034B87

Q24530090-6A489132-6C32-4670-8BA9-0D7FB9650D0D

Q24530090-72D5064B-72E2-4944-8267-661870EBC86B

Q24530090-81B47FDD-C5DF-42FE-B683-486FACFE0046

P304

Q24530090-8778554D-0208-475E-8F68-248A287BB8DF

P31

Q24530090-B39EF1D6-A950-41FD-B873-453D1FA14798

P3181

Q24530090-3AFE1BB8-1EB7-4E0E-9D5D-99C5890AA3C8

P356

Q24530090-DB08157F-E7AC-45A9-87FD-33A2ADAF309B

P407

Q24530090-14934B03-668D-44C0-8932-58B763F05AC8

P433

Q24530090-A5DEF57F-5657-49D5-A567-F8AA95711734

P478

Q24530090-8791AEA2-3754-4508-AEEA-AAB33884E74F

P50

Q24530090-0CD3AFCF-5718-46C5-9A39-8058A04A243E

Q24530090-D3B63750-6AC5-4A0A-9290-3D8B2E4C2089

P577

Q24530090-1E192851-28ED-4708-866D-E0C3C1B7D7B3

P5875

Q24530090-C454E908-6F43-4CD6-A64E-DC3BDA86500F

P698

Q24530090-6D43BCB4-09A2-403B-B0AC-3C2DBF61A5E6

P921

Q24530090-3EF1936E-A4C5-46D3-BF71-D2D57582E709

Q24530090-934E1D0C-D03C-4EBB-A835-8500E814994B

Q24530090-C26682D4-2829-474E-994A-8AE644CED34A

P932

Q24530090-00B1D2F6-8501-4BD1-8F5C-A0ED21D05D33

P3181

P356

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Erythropoietin prevents motor ...... al spinal cord ischemic injury

@en

P2093

Anthony Cerami

http://www.w3.org/2001/XMLSchema#string

Cagnur Ulukus

http://www.w3.org/2001/XMLSchema#string

Emel Sagiroglu

http://www.w3.org/2001/XMLSchema#string

Kursad Genc

http://www.w3.org/2001/XMLSchema#string

Murat Celik

http://www.w3.org/2001/XMLSchema#string

Mustafa Akhisaroglu

http://www.w3.org/2001/XMLSchema#string

Selman Konakc

http://www.w3.org/2001/XMLSchema#string

Serhat Erbayraktar

http://www.w3.org/2001/XMLSchema#string

Sermin Genc

http://www.w3.org/2001/XMLSchema#string

P2860

Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress

Erythropoietin modulates intracellular calcium in a human neuroblastoma cell line.

Erythropoietin exerts neuroprotection in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated C57/BL mice via increasing nitric oxide production.

Erythropoietin and erythropoietin receptors in the peripheral nervous system: changes after nerve injury.

Erythropoietin-mediated neuroprotection involves cross-talk between Jak2 and NF-kappaB signalling cascades.

The biology of erythropoietin in the central nervous system and its neurotrophic and neuroprotective potential.

Erythropoietin receptor is expressed in rat hippocampal and cerebral cortical neurons, and erythropoietin prevents in vitro glutamate-induced neuronal death.

Erythropoietin and erythropoietin receptor in the developing human central nervous system.

In vivo evidence that erythropoietin protects neurons from ischemic damage.

Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury.

P304

2258-2263

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

4508167

http://www.w3.org/2001/XMLSchema#string

P356

10.1073/PNAS.042693799

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

99

http://www.w3.org/2001/XMLSchema#string

P50

P577

2002-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11506171

http://www.w3.org/2001/XMLSchema#string

P698

11854521

http://www.w3.org/2001/XMLSchema#string

P921

apoptotic process

P932

122352

http://www.w3.org/2001/XMLSchema#string